Arpimune ME
- Manufactured by: Rpg Life Sciences Ltd
- Contains / Salt: Cyclosporin (100 mg)
Arpimune ME
Prescription Required
160 people have bought this recently
Select the variant of Arpimune ME
- In stock alternatives of Arpimune ME
(based on Cyclosporin (100 mg)) - Sandimmun Neoral 50 Mg Capsule (50) - ₹1890.0
- Psorid 100 Capsule - ₹368.58
- Psorid 50 Capsule - ₹189.31
- Iminoral 100 Capsule - ₹368.63
- Iminoral 50 Capsule - ₹189.33
Arpimune ME Information
Arpimune ME is a commercial drug that is prescribed in the form of Capsule, Solution. Psoriasis, Liver transplant are some of its major therapeutic uses. The alternative uses of Arpimune ME have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Arpimune ME. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Arpimune ME also has some side effects, the most common being Increased hair growth, Loss of appetite. While these are the most often observed Arpimune ME side effects, there are can be others also. These have been listed below. Such side effects of Arpimune ME normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Arpimune ME's effect during pregnancy is Severe and Severe while nursing. Warnings related to Arpimune ME's effects on the liver, heart and kidney, if any, have been listed below.
Arpimune ME is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease are examples of such conditions. Other conditions have been mentioned below in the Arpimune ME contraindications section.
Besides this, Arpimune ME may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Arpimune ME is considered safe while driving, and is addictive.
Arpimune ME Benefits & Uses
Arpimune ME is used to treat the following -
Main Benefits
- Psoriasis (Read More - Home remedies for psoriasis)
- Liver transplant
Other Benefits
Arpimune ME Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Arpimune ME Related Warnings
-
Is the use of Arpimune ME safe for pregnant women?
Pregnant women may get severe side effects after taking Arpimune ME. If you are pregnant, do not take Arpimune ME without a doctor's advice.
-
Is the use of Arpimune ME safe during breastfeeding?
Arpimune ME may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
-
What is the effect of Arpimune ME on the Kidneys?
Very few cases of side effects of Arpimune ME on kidney have been reported.
-
What is the effect of Arpimune ME on the Liver?
Very few cases of side effects of Arpimune ME on the liver have been reported.
-
What is the effect of Arpimune ME on the Heart?
You may experience side effects on your heart after taking Arpimune ME. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Severe Interaction of Arpimune ME with Other Drugs
Arpimune ME should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
Arpimune ME Contraindications
If you are suffering from any of the following diseases, you should not take Arpimune ME unless your doctor advises you to do so -
- Stomach ache
- Back Pain
- Chest Pain
- Dizziness
- Fever
- Headache
- Skin Rash
- Shortness of Breath
- Bleeding
- Constipation
- Liver Disease
- Allergy
- Psoriasis
- Kidney Disease
- Rheumatoid Arthritis
- High Cholesterol
- High Blood Pressure
- Liver Disease
- Kidney Disease
- High Uric Acid Levels in the Blood
Frequently asked Questions about Arpimune ME
-
Is this Arpimune ME habit forming or addictive?
Forming a habit of Arpimune ME has not been reported.
Arpimune ME Interactions with Food and Alcohol
-
Interaction between Food and Arpimune ME
Due to the absence of research, it is difficult to say how Arpimune ME and food will interact.
-
Interaction between Alcohol and Arpimune ME
Due to lack of research, there is no information about the side effects of taking Arpimune ME with alcohol.
See all substitutes for Arpimune ME
- Sandimmun Neoral 50 Mg Capsule (50) - ₹1890.0
- Psorid 100 Capsule - ₹368.58
- Psorid 50 Capsule - ₹189.31
- Iminoral 100 Capsule - ₹368.63
- Iminoral 50 Capsule - ₹189.33
- Sandimmun Neoral 50 Mg Capsule (1) - ₹270.0
- Oncyclo 50 Capsule - ₹258.0
- Zymmune Capsule - ₹221.9
- Sandimmun Neoral 25 Mg Capsule (50) - ₹987.0
- Cyclosporine Capsule - ₹306.0
- Sandimmun Neoral 100 Mg Capsule (50) - ₹3682.0
- Grafotas 100 Capsule - ₹368.64
- Iminoral 25 Capsule - ₹94.88
- Consiral 100 Capsule - ₹591.5
- Consiral 25 Capsule - ₹187.5
- Consiral 50 Capsule - ₹258.61
- Cyrin 100 Capsule - ₹486.2
- Cyrin 50 Capsule - ₹277.5
- Imusporin 100 Mg Capsule - ₹460.0
- Imusporin 50 Mg Capsule - ₹240.0
This medicine data has been created by -

B.Pharma, Pharmacy
3 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 879-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380